Matthew D. Blunt

The SF3B1 inhibitor spliceostatin A (SSA) elicits apoptosis in chronic lymphocytic leukaemia cells through downregulation of Mcl-1

Marta Larráyoz, Stuart J. Blakemore, Rachel Dobson et al. · Leukemia · 2015 · 103 citations · Full text

Life Sciences, Cell Biology, Oncology +14

IL-4 enhances expression and function of surface IgM in CLL cells

Montserrat Aguilar-Hernández, Matthew D. Blunt, Rachel Dobson et al. · Blood · 2016 · 91 citations · Full text

Life Sciences, Cell Biology, Immunology +13

The Dual Syk/JAK Inhibitor Cerdulatinib Antagonizes B-cell Receptor and Microenvironmental Signaling in Chronic Lymphocytic Leukemia

Matthew D. Blunt, Stefan Koehrer, Rachel Dobson et al. · Clinical Cancer Research · 2016 · 64 citations · Full text

Medicine, Oncology, Pharmacology +14

The PI3K/mTOR inhibitor PF-04691502 induces apoptosis and inhibits microenvironmental signaling in CLL and the Eµ-TCL1 mouse model

Matthew D. Blunt, Matthew Carter, Marta Larráyoz et al. · Blood · 2015 · 39 citations · Full text

Life Sciences, Cancer Biology, Oncology +14

Evidence That the Lipid Phosphatase SHIP-1 Regulates T Lymphocyte Morphology and Motility

Stephanie J. Harris, Richard V. Parry, John G. Foster et al. · The Journal of Immunology · 2011 · 37 citations · Full text

Life Sciences, Cell Biology, Immunology +17